<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9863501" created="20/05/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9863501</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="phenylarsine_oxide" sem="Organic_compound_other">Phenylarsine oxide</term> inhibits <term id="T2" lex="ex_vivo_HIV-1_expression" sem="Other">ex vivo <term id="A20" sem="DNA_domain_or_region"><term id="T3" lex="HIV-1" sem="Virus">HIV-1</term></term> expression</term>.</sentence>
<event KT="Other" id="E1">
<type class="Gene_expression"/>
<theme idref="A20"/>
<clue>Phenylarsine oxide inhibits ex vivo HIV-1 <clueType>expression</clueType>.</clue>
</event>
<event id="E2">
<type class="Negative_regulation"/>
<theme idref="E1"/>
<cause idref="T1"/>
<clue>Phenylarsine oxide <clueType>inhibits</clueType> ex vivo HIV-1 expression.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term id="T4" lex="phenylarsine_oxide" sem="Organic_compound_other">Phenylarsine oxide</term> (<term id="T5" lex="PAO" sem="Organic_compound_other">PAO</term>), which is described as an inhibitor of <term id="T6" lex="tyrosine_phosphatase_activity" sem="Other"><term id="T7" lex="tyrosine_phosphatase" sem="Protein_family_or_group"><term id="T8" lex="tyrosine" sem="Amino_acid_monomer">tyrosine</term> phosphatase</term> activity</term>, inhibits <term id="T9" lex="H2O2_release" sem="Other"><term id="A1" sem="Inorganic_compound">H2O2</term> release</term> from <term id="T10" lex="human_peripheral_blood_mononuclear_cell" sem="Cell_natural">human peripheral blood mononuclear cells</term> (<term id="T11" lex="PBMC" sem="Cell_natural">PBMCs</term>) as measured by <term id="T12" lex="electrochemistry" sem="Other">electrochemistry</term>.</sentence>
<event KT="Fact" id="E24">
<type class="Negative_regulation"/>
<theme idref="T7"/>
<cause idref="T5"/>
<clue>Phenylarsine oxide (PAO), which is described as an <clueType>inhibitor</clueType> <linkTheme>of</linkTheme> tyrosine phosphatase activity, inhibits H2O2 release from human peripheral blood mononuclear cells (PBMCs) as measured by electrochemistry.</clue>
</event>
<event KT="Fact" id="E3">
<type class="Negative_regulation"/>
<theme idref="E4"/>
<cause idref="T5"/>
<clue>Phenylarsine oxide (PAO), which is described as an inhibitor of tyrosine phosphatase activity, <clueType>inhibits</clueType> H2O2 release from human peripheral blood mononuclear cells (PBMCs) as measured by electrochemistry.</clue>
</event>
<event KT="Other" id="E4">
<type class="Localization"/>
<theme idref="A1"/>
<clue>Phenylarsine oxide (PAO), which is described as an inhibitor of tyrosine phosphatase activity, inhibits H2O2 <clueType>release</clueType> <clueLoc>from human peripheral blood mononuclear cells (PBMCs)</clueLoc> as measured <clueExperiment>by electrochemistry</clueExperiment>.</clue>
</event>
<sentence id="S3">Since <term id="T13" lex="human_immunodeficiency_virus_type_1_(HIV-1)_replication" sem="Other"><term id="T14" lex="human_immunodeficiency_virus_type_1" sem="Virus">human immunodeficiency virus type 1</term> (<term id="T15" lex="HIV-1" sem="Virus">HIV-1</term>) replication</term> is known to be favored under <term id="T16" lex="oxidative_stress" sem="Other">oxidative stress</term> conditions, <term id="T17" lex="ex_vivo_experiment" sem="Other">ex vivo experiments</term> using uninfected <term id="T18" lex="PBMC" sem="Cell_natural">PBMCs</term>, <term id="T19" lex="primary_monocyte" sem="Cell_natural">primary monocytes</term> or a latently infected <term id="T20" lex="promonocytic_U1_cell_line" sem="Cell_cultured">promonocytic U1 cell line</term> show that <term id="T21" lex="HIV-1" sem="Virus">HIV-1</term> replication and reactivation, monitored by <term id="T22" lex="p24_antigen_measurement" sem="Other"><term id="T23" lex="p24_antigen" sem="Protein_molecule">p24 antigen</term> measurement</term>, are inhibited by <term id="T24" lex="PAO" sem="Organic_compound_other">PAO</term> in a <term id="T25" lex="time-_and_concentration-dependent_manner" sem="Other">time- and concentration-dependent manner</term>.</sentence>
<event KT="Fact" id="E5">
<type class="Positive_regulation"/>
<theme idref="E6"/>
<cause idref="T16"/>
<clue>Since human immunodeficiency virus type 1 (HIV-1) replication is <clueKT>known</clueKT> to be <clueType>favored</clueType> <linkCause>under</linkCause> oxidative stress conditions, ex vivo experiments using uninfected PBMCs, primary monocytes or a latently infected promonocytic U1 cell line show that HIV-1 replication and reactivation, monitored by p24 antigen measurement, are inhibited by PAO in a time- and concentration-dependent manner.</clue>
</event>
<event KT="Other" id="E6">
<type class="Viral_life_cycle"/>
<theme idref="T15"/>
<clue>Since human immunodeficiency virus type 1 (HIV-1) <clueType>replication</clueType> is known to be favored under oxidative stress conditions, ex vivo experiments using uninfected PBMCs, primary monocytes or a latently infected promonocytic U1 cell line show that HIV-1 replication and reactivation, monitored by p24 antigen measurement, are inhibited by PAO in a time- and concentration-dependent manner.</clue>
</event>
<event KT="Other" id="E25">
<type class="Viral_life_cycle"/>
<theme idref="T21"/>
<clue>Since human immunodeficiency virus type 1 (HIV-1) replication is known to be favored under oxidative stress conditions, ex vivo experiments using uninfected PBMCs, primary monocytes or a latently infected promonocytic U1 cell line show that HIV-1 <clueType>replication</clueType> and reactivation, monitored <clueExperiment>by p24 antigen measurement</clueExperiment>, are inhibited by PAO in a time- and concentration-dependent manner.</clue>
</event>
<event KT="Other" id="E8">
<type class="Viral_life_cycle"/>
<theme idref="T21"/>
<clue>Since human immunodeficiency virus type 1 (HIV-1) replication is known to be favored under oxidative stress conditions, ex vivo experiments using uninfected PBMCs, primary monocytes or a <clueLoc>latently infected promonocytic U1 cell line</clueLoc> show that HIV-1 replication and <clueType>reactivation</clueType>, monitored <clueExperiment>by p24 antigen measurement</clueExperiment>, are inhibited by PAO in a time- and concentration-dependent manner.</clue>
</event>
<event KT="Analysis" id="E9">
<type class="Negative_regulation"/>
<theme idref="E25"/>
<cause idref="T24"/>
<clue>Since human immunodeficiency virus type 1 (HIV-1) replication is known to be favored under oxidative stress conditions, ex vivo experiments using uninfected PBMCs, primary monocytes or a latently infected promonocytic U1 cell line <clueKT>show</clueKT> that HIV-1 replication and reactivation, monitored by p24 antigen measurement, are <clueType>inhibited</clueType> <linkCause>by</linkCause> PAO in a time- and concentration-dependent manner.</clue>
</event>
<event KT="Analysis" id="E10">
<type class="Negative_regulation"/>
<theme idref="E8"/>
<cause idref="T24"/>
<clue>Since human immunodeficiency virus type 1 (HIV-1) replication is known to be favored under oxidative stress conditions, ex vivo experiments using uninfected PBMCs, primary monocytes or a latently infected promonocytic U1 cell line <clueKT>show</clueKT> that HIV-1 replication and reactivation, monitored by p24 antigen measurement, are <clueType>inhibited</clueType> <linkCause>by</linkCause> PAO in a time- and concentration-dependent manner.</clue>
</event>
<sentence id="S4">These observations can be linked with the inhibition of <term id="T26" lex="NF-kappa_B_activation" sem="Other"><term id="T27" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> activation</term> when uninfected <term id="A2" sem="Cell_natural">monocytes</term> are induced by either <term id="T28" lex="tumor_necrosis_factor_alpha" sem="Protein_molecule">tumor necrosis factor alpha</term> (<term id="T29" lex="TNF-alpha" sem="Protein_molecule">TNF-alpha</term>) <term id="T30" lex="phorbol_12-myristate_13-acetate" sem="Organic_compound_other">phorbol 12-myristate 13-acetate</term> (<term id="T31" lex="PMA" sem="Organic_compound_other">PMA</term>) or <term id="T32" lex="lipopolysaccharide" sem="Lipid">lipopolysaccharide</term> (<term id="T33" lex="LPS" sem="Lipid">LPS</term>).</sentence>
<event KT="Other" id="E11">
<type class="Positive_regulation"/>
<theme idref="T27"/>
<clue>These observations can be linked with the inhibition of NF-kappa B <clueType>activation</clueType> when uninfected monocytes are induced by either tumor necrosis factor alpha (TNF-alpha) phorbol 12-myristate 13-acetate (PMA) or lipopolysaccharide (LPS).</clue>
</event>
<event KT="Other" id="E12">
<type class="Negative_regulation"/>
<theme idref="E11"/>
<cause idref="E15"/>
<clue>These observations can be linked with the <clueType>inhibition</clueType> <linkTheme>of</linkTheme> NF-kappa B activation <linkCause>when</linkCause> uninfected monocytes are induced by either tumor necrosis factor alpha (TNF-alpha) phorbol 12-myristate 13-acetate (PMA) or lipopolysaccharide (LPS).</clue>
</event>
<event KT="Other" id="E13">
<type class="Negative_regulation"/>
<theme idref="E11"/>
<cause idref="E16"/>
<clue>These observations can be linked with the <clueType>inhibition</clueType> <linkTheme>of</linkTheme> NF-kappa B activation <linkCause>when</linkCause> uninfected monocytes are induced by either tumor necrosis factor alpha (TNF-alpha) phorbol 12-myristate 13-acetate (PMA) or lipopolysaccharide (LPS).</clue>
</event>
<event KT="Other" id="E14">
<type class="Negative_regulation"/>
<theme idref="E11"/>
<cause idref="E17"/>
<clue>These observations can be linked with the <clueType>inhibition</clueType> <linkTheme>of</linkTheme> NF-kappa B activation <linkCause>when</linkCause> uninfected monocytes are induced by either tumor necrosis factor alpha (TNF-alpha) phorbol 12-myristate 13-acetate (PMA) or lipopolysaccharide (LPS).</clue>
</event>
<event KT="Other" id="E15">
<type class="Physiological_process"/>
<theme idref="A2"/>
<cause idref="T29"/>
<clue>These observations can be linked with the inhibition of NF-kappa B activation when uninfected monocytes are <clueType>induced</clueType> <linkCause>by</linkCause> either tumor necrosis factor alpha (TNF-alpha) phorbol 12-myristate 13-acetate (PMA) or lipopolysaccharide (LPS).</clue>
<comment>CAUTION, there should be a comma after &quot;(TNF-alpha)&quot;</comment></event>
<event KT="Other" id="E16">
<type class="Physiological_process"/>
<theme idref="A2"/>
<cause idref="T31"/>
<clue>These observations can be linked with the inhibition of NF-kappa B activation when uninfected monocytes are <clueType>induced</clueType> <linkCause>by</linkCause> either tumor necrosis factor alpha (TNF-alpha) phorbol 12-myristate 13-acetate (PMA) or lipopolysaccharide (LPS).</clue>
</event>
<event KT="Other" id="E17">
<type class="Physiological_process"/>
<theme idref="A2"/>
<cause idref="T33"/>
<clue>These observations can be linked with the inhibition of NF-kappa B activation when uninfected monocytes are <clueType>induced</clueType> <linkCause>by</linkCause> either tumor necrosis factor alpha (TNF-alpha) phorbol 12-myristate 13-acetate (PMA) or lipopolysaccharide (LPS).</clue>
</event>
<event CL="L2" KT="Analysis" id="E18">
<type class="Correlation"/>
<theme idref="E9"/>
<theme idref="E12"/>
<clue><corefTheme>These observations</corefTheme> <clueCL>can</clueCL> be <clueType><clueKT>linked</clueKT></clueType> <linkTheme>with</linkTheme> the inhibition of NF-kappa B activation when uninfected monocytes are induced by either tumor necrosis factor alpha (TNF-alpha) phorbol 12-myristate 13-acetate (PMA) or lipopolysaccharide (LPS).</clue>
</event>
<event CL="L2" KT="Analysis" id="E19">
<type class="Correlation"/>
<theme idref="E9"/>
<theme idref="E13"/>
<clue><corefTheme>These observations</corefTheme> <clueCL>can</clueCL> be <clueType><clueKT>linked</clueKT></clueType> <linkTheme>with</linkTheme> the inhibition of NF-kappa B activation when uninfected monocytes are induced by either tumor necrosis factor alpha (TNF-alpha) phorbol 12-myristate 13-acetate (PMA) or lipopolysaccharide (LPS).</clue>
</event>
<event CL="L2" KT="Analysis" id="E20">
<type class="Correlation"/>
<theme idref="E9"/>
<theme idref="E14"/>
<clue><corefTheme>These observations</corefTheme> <clueCL>can</clueCL> be <clueType><clueKT>linked</clueKT></clueType> <linkTheme>with</linkTheme> the inhibition of NF-kappa B activation when uninfected monocytes are induced by either tumor necrosis factor alpha (TNF-alpha) phorbol 12-myristate 13-acetate (PMA) or lipopolysaccharide (LPS).</clue>
</event>
<event CL="L2" KT="Analysis" id="E21">
<type class="Correlation"/>
<theme idref="E10"/>
<theme idref="E12"/>
<clue><corefTheme>These observations</corefTheme> <clueCL>can</clueCL> be <clueType><clueKT>linked</clueKT></clueType> <linkTheme>with</linkTheme> the inhibition of NF-kappa B activation when uninfected monocytes are induced by either tumor necrosis factor alpha (TNF-alpha) phorbol 12-myristate 13-acetate (PMA) or lipopolysaccharide (LPS).</clue>
</event>
<event CL="L2" KT="Analysis" id="E22">
<type class="Correlation"/>
<theme idref="E10"/>
<theme idref="E13"/>
<clue><corefTheme>These observations</corefTheme> <clueCL>can</clueCL> be <clueType><clueKT>linked</clueKT></clueType> <linkTheme>with</linkTheme> the inhibition of NF-kappa B activation when uninfected monocytes are induced by either tumor necrosis factor alpha (TNF-alpha) phorbol 12-myristate 13-acetate (PMA) or lipopolysaccharide (LPS).</clue>
</event>
<event CL="L2" KT="Analysis" id="E23">
<type class="Correlation"/>
<theme idref="E10"/>
<theme idref="E14"/>
<clue><corefTheme>These observations</corefTheme> <clueCL>can</clueCL> be <clueType><clueKT>linked</clueKT></clueType> <linkTheme>with</linkTheme> the inhibition of NF-kappa B activation when uninfected monocytes are induced by either tumor necrosis factor alpha (TNF-alpha) phorbol 12-myristate 13-acetate (PMA) or lipopolysaccharide (LPS).</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
